Accès gratuit
Numéro
Med Sci (Paris)
Volume 32, Numéro 1, Janvier 2016
Origine développementale de la santé et des maladies (DOHaD), environnement et épigénétique
Page(s) 110 - 115
Section Prix Nobel 2015
DOI https://doi.org/10.1051/medsci/20163201018
Publié en ligne 5 février 2016
  1. Burg RW, Miller BM, Baker EE, et al. Omura S. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 1979 ; 15 : 361–367. [CrossRef] [PubMed]
  2. Miller TW, Chaiet L, Cole DJ, et al. Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties. Antimicrob Agents Chemother 1979 ; 15 : 368–371. [CrossRef] [PubMed]
  3. Egerton JR, Ostlind DA, Blair LS, et al. Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component. Antimicrob Agents Chemother 1979 ; 15 : 372–378. [CrossRef] [PubMed]
  4. Kass IS, Wang CC, Walrond JP, Stretton AO. Avermectin B1a, a paralyzing anthelmintic that affects interneurons and inhibitory motoneurons in Ascaris. Proc Natl Acad Sci USA 1980 ; 77 : 6211–6215. [CrossRef]
  5. Aziz MA, Diallo S, Diop IM, et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet. 1982 ; 2 : 171–173. [CrossRef] [PubMed]
  6. Campbell WC, Fisher MH, Stapley EO, et al. Ivermectin: a potent new antiparasitic agent. Science 1983 ; 221 : 823–828. [CrossRef] [PubMed]
  7. Larivière M, Vingtain P, Aziz M, et al. Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. Lancet 1985 ; 27 ; 2 : 174–177. [CrossRef]
  8. Greene BM, Taylor HR, Cupp EW, et al. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 1985 ; 313 : 133–138. [CrossRef] [PubMed]
  9. Richard-Lenoble D, Kombila M, Rupp EA, et al. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am J Trop Med Hyg 1988 ; 39 : 480–483. [CrossRef] [PubMed]
  10. Gardon J, Gardon-Wendel N, Demanga-Ngangue, et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997 ; 350 : 18–22. [CrossRef] [PubMed]
  11. Omura S, Crump A. The life and times of ivermectin: a success story. Nat Rev Microbiol 2004 ; 2 : 984–989. [CrossRef] [PubMed]
  12. Campbell WC. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. Curr Pharm Biotechnol 2012 ; 13 : 853–865. [CrossRef]
  13. Organisation mondiale de la santé/ Programme africain de lutte contre l’onchocercose (APOC). Rapport d’activité 2013. www.who.int/entity/apoc/publications/2013_progressreport/fr/.
  14. Organisation mondiale de la santé. Onchocercose. Aide-mémoire n°374, mars 2015. http://www.who.int/mediacentre/factsheets/fs374/fr/.
  15. Al Qubati Y, Reynouard F, Kumar F, et al. Onchodermatite (Sowda) au Yémen : évolution clinique et histologique après traitement par l’ivermectine. Santé 1997; 7 : 391–395.
  16. Diallo S, Aziz MA, Ndir O, Badiane S, Bah IB, Gaye O. Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti. Lancet 1987 ; 1 : 1030. [CrossRef]
  17. Organisation mondiale de la santé. Filariose lymphatique. Aide-mémoire n° 102, mai 2015. http://www.who.int/mediacentre/factsheets/fs102/fr/.
  18. Ottesen EA, Vijayasekaran V, Kumaraswami V, et al. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. N Engl J Med 1990 ; 322 : 1113–1117. [CrossRef] [PubMed]
  19. Cartel JL, Celerier P, Spiegel A, et al. Effect of two successive annual treatments with single doses of ivermectin on microfilaraemia due to Wuchereria bancrofti var. pacifica. Trans R Soc Trop Med Hyg 1990 ; 84 : 837–839. [CrossRef] [PubMed]
  20. Bockarie MJ, Alexander ND, Hyun P, et al. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet 1998 ; 351 : 162–168. [CrossRef] [PubMed]
  21. Addiss DG, Beach MJ, Streit TG, et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 1997 ; 350 : 480–484. [CrossRef] [PubMed]
  22. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999 ; 15 : 382–386. [CrossRef] [PubMed]
  23. Horton J, Witt C, Ottesen EA, et al. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000 ; 121 (suppl) : S147–S160. [CrossRef] [PubMed]
  24. Thomsen EK, Sanuku N, Baea M, et al. Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of Bancroftian filariasis. Clin Infect Dis 2015; pii : civ882.
  25. Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 2000 ; 5 : 591–594. [CrossRef] [PubMed]
  26. Evans DS, Unnasch TR, Richards FO. Onchocerciasis and lymphatic filariasis elimination in Africa: it’s about time. Lancet 2015 ; 385 : 2151–2152. [CrossRef]
  27. Krotneva SP, Coffeng LE, Noma M, et al. African program for onchocerciasis control 1995–2010: impact of annual Ivermectin mass treatment on off-target infectious diseases. PLoS Negl Trop Dis 2015 ; 9 : e0004051. [CrossRef] [PubMed]
  28. Nozais JP, Thellier M, Datry A, Danis M. Anguillulose disséminée. Presse Med 2001 ; 30 : 813–818.
  29. Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993 ; 49 : 641–644. [CrossRef] [PubMed]
  30. Ly F, Caumes E, Ndaw CA, et al. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ 2009 ; 87 : 424–430. [CrossRef] [PubMed]
  31. Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med 2010 ; 362 : 717–725. [CrossRef] [PubMed]
  32. Chosidow O, Giraudeau B, Cottrell J, et al. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med 2010 ; 362 : 896–905. [CrossRef] [PubMed]
  33. Gentilini M, Richard-Lenoble D, Gentilini M, Caumes E, Danis M, Richard-Lenoble D, Bégué P, Touze JE, Kerouédan D. Filarioses. Médecine tropicale. Paris : Lavoisier, 2012 : 322–349.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.